157 related articles for article (PubMed ID: 38668045)
1. Radiological and Not Clinical Variables Guide the Surgical Plan in Patients with Glioblastoma.
Martín-Abreu C; Fariña-Jerónimo H; Plata-Bello J
Curr Oncol; 2024 Apr; 31(4):1899-1912. PubMed ID: 38668045
[No Abstract] [Full Text] [Related]
2. Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients.
Hallaert G; Pinson H; Vanhauwaert D; Van den Broecke C; Van Roost D; Boterberg T; Kalala JP
Surg Oncol; 2020 Dec; 35():515-519. PubMed ID: 33152608
[TBL] [Abstract][Full Text] [Related]
3. Safety and outcomes of resection of butterfly glioblastoma.
Dayani F; Young JS; Bonte A; Chang EF; Theodosopoulos P; McDermott MW; Berger MS; Aghi MK
Neurosurg Focus; 2018 Jun; 44(6):E4. PubMed ID: 29852771
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
5. Surgical Resection of Anterior and Posterior Butterfly Glioblastoma.
Opoku-Darko M; Amuah JE; Kelly JJP
World Neurosurg; 2018 Feb; 110():e612-e620. PubMed ID: 29162526
[TBL] [Abstract][Full Text] [Related]
6. Combined use of multimodal techniques for the resection of glioblastoma involving corpus callosum.
Cui M; Chen H; Sun G; Liu J; Zhang M; Lin H; Sun C; Ma X
Acta Neurochir (Wien); 2022 Mar; 164(3):689-702. PubMed ID: 34636967
[TBL] [Abstract][Full Text] [Related]
7. Surgery for IDH1/2 wild-type glioma invading the corpus callosum.
Franco P; Delev D; Cipriani D; Neidert N; Kellner E; Masalha W; Mercas B; Mader I; Reinacher P; Weyerbrock A; Fung C; Beck J; Heiland DH; Schnell O
Acta Neurochir (Wien); 2021 Apr; 163(4):937-945. PubMed ID: 33095353
[TBL] [Abstract][Full Text] [Related]
8. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?
Pala A; Schmitz AL; Knoll A; Schneider M; Hlavac M; König R; Wirtz CR; Coburger J
Clin Neurol Neurosurg; 2018 Apr; 167():6-10. PubMed ID: 29425743
[TBL] [Abstract][Full Text] [Related]
9. MGMT-Positive vs MGMT-Negative Patients With Glioblastoma: Identification of Prognostic Factors and Resection Threshold.
Katsigiannis S; Grau S; Krischek B; Er K; Pintea B; Goldbrunner R; Stavrinou P
Neurosurgery; 2021 Mar; 88(4):E323-E329. PubMed ID: 33432978
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival after glioblastoma resection: hope despite poor prognosis factors.
Costa E; Lawson TM; Lelotte J; Fomekong E; Vaz RG; Renard L; Whenham N; Raftopoulos C
J Neurosurg Sci; 2019 Jun; 63(3):251-257. PubMed ID: 29363298
[TBL] [Abstract][Full Text] [Related]
11. Pseudoprogression in glioblastoma patients: the impact of extent of resection.
Park HH; Roh TH; Kang SG; Kim EH; Hong CK; Kim SH; Ahn SS; Lee SK; Choi HJ; Cho J; Kim SH; Lee KS; Suh CO; Chang JH
J Neurooncol; 2016 Feb; 126(3):559-66. PubMed ID: 26608521
[TBL] [Abstract][Full Text] [Related]
12. On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions.
Müller DMJ; Robe PA; Ardon H; Barkhof F; Bello L; Berger MS; Bouwknegt W; Van den Brink WA; Conti Nibali M; Eijgelaar RS; Furtner J; Han SJ; Hervey-Jumper SL; Idema AJS; Kiesel B; Kloet A; Mandonnet E; De Munck JC; Rossi M; Sciortino T; Vandertop WP; Visser M; Wagemakers M; Widhalm G; Witte MG; Zwinderman AH; De Witt Hamer PC
J Neurosurg; 2022 Jan; 136(1):45-55. PubMed ID: 34243150
[TBL] [Abstract][Full Text] [Related]
13. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy.
Kreth FW; Thon N; Simon M; Westphal M; Schackert G; Nikkhah G; Hentschel B; Reifenberger G; Pietsch T; Weller M; Tonn JC;
Ann Oncol; 2013 Dec; 24(12):3117-23. PubMed ID: 24130262
[TBL] [Abstract][Full Text] [Related]
14. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
[TBL] [Abstract][Full Text] [Related]
15. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
16. Pre-Operative Perfusion Skewness and Kurtosis Are Potential Predictors of Progression-Free Survival after Partial Resection of Newly Diagnosed Glioblastoma.
Paik W; Kim HS; Choi CG; Kim SJ
Korean J Radiol; 2016; 17(1):117-26. PubMed ID: 26798224
[TBL] [Abstract][Full Text] [Related]
17. Early post-operative magnetic resonance imaging in glioblastoma: correlation among radiological findings and overall survival in 60 patients.
Majós C; Cos M; Castañer S; Gil M; Plans G; Lucas A; Bruna J; Aguilera C
Eur Radiol; 2016 Apr; 26(4):1048-55. PubMed ID: 26188660
[TBL] [Abstract][Full Text] [Related]
18. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A
J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594
[TBL] [Abstract][Full Text] [Related]
19. Maximal surgical resection and adjuvant surgical technique to prolong the survival of adult patients with thalamic glioblastoma.
Lim J; Park Y; Ahn JW; Hwang SJ; Kwon H; Sung KS; Cho K
PLoS One; 2021; 16(2):e0244325. PubMed ID: 33539351
[TBL] [Abstract][Full Text] [Related]
20. Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value And Association to Postoperative Infarct Volume.
Bette S; Barz M; Huber T; Straube C; Schmidt-Graf F; Combs SE; Delbridge C; Gerhardt J; Zimmer C; Meyer B; Kirschke JS; Boeckh-Behrens T; Wiestler B; Gempt J
Sci Rep; 2018 Mar; 8(1):4561. PubMed ID: 29540809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
